To view or add a comment, sign in 956 followers
Butterworth, P
1: Pharmacies can't stock enough to keep up with demand 2: Many insurance companies aren't covering these medications for weight loss When it comes to obesity, Medicare recently announced it would cover these drugs for obese patients who have cardiovascular disease
Discussion In this database study, treatment with semaglutide (against sitagliptin, a placebo proxy) led to a reduced risk of MACE, and tirzepatide (against dulaglutide) demonstrated a similar risk reduction in patients at elevated cardiovascular risk with obesity and type 2 diabetes
The way, you know, the amount of time that we have for preparing food and eating it with our friends and relations, and what sort of foods are easily available to us as well, to actually change the environment to be more supportive, and address those structural factors that are really driving these high rates of obesity and weight loss
Effect of sod (superoxide dismutase) protein supplementation in semen extenders on mobility, viability, acrosome status and ERK (extracellular signal-regulated kinase) protein phosphorylation of chilled stallion spermatozoa